Replies to post #780600 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

zero82,

“I hear..” 😶 Source, please?

Thanks for reposting your free psychic predictions, but it sounds like you’re just spreading baseless rumors.



I thought you advised us to stick to “only hard facts” 😶 ..and we are much more interested in reliable sources & FACTS.

Examples of Reliable Sources:
☑️ Regulatory Agencies
☑️ U.S. DoD Grant Peer Reviewers
☑️ U.S. NIH Grant Peer Reviewers
☑️ Independently Peer-Reviewed Medical Journals
☑️ UCLA Jonsson Comprehensive Cancer Center
(NCI-Designated Cancer Center)
☑️ University of Pittsburgh Hillman Cancer Center
(NCI-Designated Cancer Center)
☑️ Roswell Park Comprehensive Cancer Institute
(NCI-Designated Cancer Center)

“Later this fall,” we want to see further updates & interim data on clinical trials. PII is a key stage for combo studies. New or expanded trials may soon be underway depending on funding & new partnerships or expansion of existing collaborations…

For example, we’re all interested in factual developments related to this PII Combo Trial at Roswell Park —
✅️ recently updated on clinicaltrials.gov
✅️ recently published/promoted at ASCO
✅️ recently expanded in scope
✅️ supported by a competitive peer-reviewed grant awarded by the U.S. DoD
✅️ includes Merck’s pembrolizumab
✅️ has a trial site at Moffitt in Florida
✅️ is currently active & recruiting

NCT04348747

NCI-Designated Cancer Centers